Results 171 to 180 of about 4,903,700 (215)

Addendum: RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions. [PDF]

J Exp Med
Hogstad B, Berres ML, Chakraborty R, Tang J, Bigenwald C, Serasinghe M, Lim KPH, Lin H, Man TK, Remark R, Baxter S, Kana V, Jordan S, Karoulia Z, Kwan WH, Leboeuf M, Brandt E, Salmon H, McClain K, Poulikakos P, Chipuk J, Mulder WJM, Allen CE, Merad M.   +23 more
europepmc   +1 more source

Age-Stratified Imaging Selection in Langerhans Cell Histiocytosis: Towards a Clinical Decision Framework. [PDF]

J Clin Med
Gettleman B, Jeong S, Joachim K, Fice M, Lin A, Abernethy C, Dingle E, Perrotta A, Richards AE, Bernthal NM, Christ AB.   +10 more
europepmc   +1 more source

Langerhans' cell histiocytosis

The Lancet, 2005
A 38-year-old woman complained of persistent chest pain. A plain radiograph showed an irregularity on the sternum, and bone-scan showed uptake only in that area. Thoracic-abdominal CT showed an osteolytic lesion of the sternum (figure) without any other signs of neoplasia.
N. Fazio, L. Spaggiari, G. Pelosi, F. Presicci, L. Preda   +4 more
openaire   +5 more sources

Some of the next articles are maybe not open access.

Related searches:

Adult Langerhans cell histiocytosis

European Journal of Haematology, 2006
Abstract:  Langerhans cell histiocytosis (LCH) is a proliferative histiocytic disorder of unknown cause originating from dendritic cells. The clinical presentation of LCH is highly variable. Although the features of this disease have been well described in children, they remain poorly defined in adults. Here, we review the current knowledge about adult
Marcus, Stockschlaeder, Christoph, Sucker   +1 more
exaly   +3 more sources

Biology of Langerhans Cells and Langerhans Cell Histiocytosis

International Review of Cytology, 2006
Langerhans cells (LC) are epidermal dendritic cells (DC). They play an important role in the initiation of immune responses through antigen uptake, processing, and presentation to T cells. Langerhans cell histiocytosis (LCH) is a rare disease in which accumulation of cells with LC characteristics (LCH cells) occur. LCH lesions are further characterized
R J Arceci, R M Egeler
exaly   +3 more sources

Langerhans cell histiocytosis

Journal of the American Academy of Dermatology, 2001
From the Department of Radiology, Division of Neuroradiology,a and the Department of Dermatology,b Indiana University Medical Center; and the Department of Oral Surgery Medicine and Pathology, Indiana University School of Dentistry.c Reprint requests: Ginat W. Mirowski, DMD, MD, Department of Dermatology, 550 N University Blvd, Suite 3240, Indianapolis,
K S, Caldemeyer, E T, Parks, G W, Mirowski   +2 more
  +7 more sources

Langerhans Cell Histiocytosis

Dermatology, 2009
Langerhans cell histiocytosis is a rare disease. Depending on which organs are involved, the disease may prove rapidly fatal, develop a chronic reactivating but therapy-responsive pattern or resolve spontaneously. Understanding of the pathology of the disease is progressing rapidly, and while clinical trials of standard chemotherapy agents continue, it
K, Windebank, V, Nanduri
openaire   +4 more sources

Langerhans’ Cell Histiocytosis

Orthopedic Clinics of North America, 1996
Langerhans' Cell Histiocytosis, formerly known as Histiocytosis X, and its related syndromes (i.e., eosinophilic granuloma, Hand-Schuller-Christian disease, and Letterer-Siwe disease) are briefly reviewed. The biology, clinical manifestations, and treatment options of the localized, single form and the disseminated, multisystem form are also discussed.
M C, Velez-Yanguas, R P, Warrier
openaire   +2 more sources